Antidote AI
PrivateLast Round
Seed
Jan 21, 2026
Total Funding Raised
$7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Antidote AI operates in Healthcare & Life Sciences and is based in the United States. Its latest recorded funding round was a Seed round in January 2026.
Antidote AI is a healthcare technology company that provides a conversational clinical operating system designed to automate clinical workflows, documentation, and decision support for medical providers.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, Workflow Automation, EHR & EMR, Document Management
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antidote AI Comparables
Compare Antidote AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HealOS | 91% | |
| Ambience Healthcare | 81% | |
| Freed | 80% |
For institutional investors. Book with your work email.
Antidote AI Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Antidote AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lakestar | Seed |
| The LegalTech Fund | Seed |
| Concept Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
$5M round led by Lakestar
For institutional investors. Book with your work email.
Antidote AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Antidote AI's valuation, stock price, and market status.
Is Antidote AI a public or private company?
Antidote AI is a private company.
What is the current stock price of Antidote AI?
Antidote AI is a private company, so its shares have no public market price. Caplight tracks Antidote AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Antidote AI worth (valuation)?
Valuation information for Antidote AI is not publicly available.
Can I buy Antidote AI stock?
Antidote AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Antidote AI's last funding round?
Antidote AI's most recent funding round was Seed on January 21, 2026.
Who are the main investors in Antidote AI?
Key investors in Antidote AI include Lakestar.
Will Antidote AI IPO soon?
No public IPO plans have been announced for Antidote AI.
How can I track Antidote AI secondary market activity?
Caplight tracks bids, offers, and trades in Antidote AI's shares on secondary markets.